Berlin - Delayed Quote EUR
Syndax Pharmaceuticals Inc (1T3.BE)
12.00
-0.50
(-4.00%)
At close: May 2 at 9:52:09 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-274,903
-274,903
-160,601
-133,675
29,131
Investing Cash Flow
-219,775
-219,775
117,609
-186,188
-40,873
Financing Cash Flow
353,367
353,367
264,132
172,254
118,464
End Cash Position
154,300
154,300
295,611
74,471
222,080
Interest Paid Supplemental Data
--
--
--
2,059
1,997
Capital Expenditure
--
--
--
--
-129
Issuance of Capital Stock
--
--
258,094
181,390
86,337
Repayment of Debt
--
--
--
-20,996
--
Free Cash Flow
-274,903
-274,903
-160,601
-133,675
29,002
12/31/2021 - 4/30/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VX1.MU Vertex Pharmaceuticals Inc
439.25
-0.82%
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
VX1.HA Vertex Pharmaceuticals Inc
439.60
-0.92%
VX1.DU Vertex Pharmaceuticals Inc
440.35
-0.94%
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
VRTX.VI Vertex Pharmaceuticals Incorporated
440.30
-1.21%
VX1.BE Vertex Pharmaceuticals Inc
444.00
+0.90%
VX1.HM Vertex Pharmaceuticals Inc
439.65
-0.91%
ALZCUR.ST AlzeCure Pharma AB (publ)
2.4500
+3.38%
AC6.F AlzeCure Pharma AB (publ)
0.1755
-0.85%